Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00827359
Recruitment Status : Active, not recruiting
First Posted : January 22, 2009
Last Update Posted : June 29, 2017
Duke University
Information provided by (Responsible Party):
David F. McDermott, MD, Beth Israel Deaconess Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 2018
  Estimated Study Completion Date : June 2018